Anna Sofie Kappel Buhl

5PUBLICATIONS

26CO-AUTHORS

Haematological tumoursPharmacogenomicsGene and molecular therapyPredictive and prognostic markers

Get your video featured.

Publish with JoVE

Get your video featured.

Publish with JoVE

Publications (5)

Sort by Publication Date:

|Jun 18, 2026

Central nervous system penetration of imatinib in acute lymphoblastic leukemia: Pharmacokinetic analysis and clinical implications.

|May 28, 2026

Pharmacokinetic profiling of imatinib in relation to CYP3A4 activity in leukaemia patients.

|Sep 08, 2025

Published Population Pharmacokinetic Models of Imatinib Perform Poorly on TDM Data from Pediatric Patients.

Tianwu Yang, Anna Sofie Buhl Rasmussen, Allan Weimann

|Jul 16, 2025

DNA-incorporated thioguanine to detect potential non-adherence to maintenance therapy in acute lymphoblastic leukemia.

Mathilde Rønne Koch, Anna Sofie Buhl Rasmussen, Bodil Als-Nielsen

|Aug 13, 2018

Predicting efficacy of epirubicin by a multigene assay in advanced breast cancer within a Danish Breast Cancer Cooperative Group (DBCG) cohort: a retrospective-prospective blinded study.

Anna Sofie Kappel Buhl, Troels Dreier Christensen, Ib Jarle Christensen

Pageof 1

Frequent Collaborators

Maria Thastrup

Kjeld Schmiegelow

Trine Meldgaard Lund

Kim Dalhoff

Tianwu Yang

Cecilie Utke Rank

Christen Lykkegaard Andersen

2 joint publications

Ib Jarle Christensen

2 joint publications

Goda Vaitkeviciene

2 joint publications

Hilde Skuterud Wik

Frequent Collaborators

Maria Thastrup

Kjeld Schmiegelow

Trine Meldgaard Lund

Kim Dalhoff